Key FDA committee unanimously recommends its first vaccine since 2023

MAP Verified Summary — reported by NPR Politics

All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.

This story’s context record documents 7 observable dimensions — Origin, Attribution, Specificity, Timing, Framing, Context Change, and Information Relationships — as part of Media Alert Press’s context-documentation ledger. MAP does not score or rate this content. Read the full original story at NPR Politics →

View MAP Context →